Jerrold H Levy Selected Research

Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

1/2022	Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study.
1/2020	Coagulopathy of Coronavirus Disease 2019.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerrold H Levy Research Topics

Disease

105	Hemorrhage 05/2024 - 06/2003
43	Thrombosis (Thrombus) 05/2024 - 02/2007
37	Sepsis (Septicemia) 05/2024 - 10/2013
30	Disseminated Intravascular Coagulation 05/2024 - 10/2013
28	Thrombocytopenia (Thrombopenia) 03/2024 - 07/2005
23	Inflammation (Inflammations) 01/2024 - 02/2003
19	COVID-19 03/2024 - 01/2020
19	Wounds and Injuries (Trauma) 01/2023 - 03/2008
17	Critical Illness (Critically Ill) 05/2024 - 02/2013
16	Infections 02/2024 - 10/2018
12	Myocardial Infarction 01/2017 - 05/2004
10	Atrial Fibrillation 11/2022 - 09/2005
9	Shock 03/2023 - 02/2008
9	Stroke (Strokes) 10/2022 - 09/2005
6	Thromboembolism 05/2024 - 01/2020
5	Anaphylaxis (Anaphylactic Shock) 05/2024 - 06/2004
5	Venous Thromboembolism 01/2021 - 07/2012
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 09/2014
4	Hypotension (Low Blood Pressure) 09/2023 - 04/2002
4	Septic Shock (Toxic Shock Syndrome) 01/2022 - 10/2017
4	Thrombophilia 12/2020 - 01/2011
4	Hypertension (High Blood Pressure) 08/2014 - 05/2002
4	Vascular System Injuries 02/2011 - 06/2006
3	Communicable Diseases (Infectious Diseases) 02/2024 - 01/2021
3	Thromboinflammation 02/2024 - 05/2023
3	Pneumonia (Pneumonitis) 12/2023 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 10/2023 - 02/2016
3	Hypoxia (Hypoxemia) 01/2023 - 01/2020
3	Disease Progression 01/2023 - 09/2006
3	Postpartum Hemorrhage 01/2023 - 05/2014
3	Pulmonary Embolism 01/2022 - 10/2017
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2017
3	Renal Insufficiency (Renal Failure) 01/2020 - 09/2005
3	Left Ventricular Dysfunction 01/2020 - 12/2016
3	Hemophilia A (Haemophilia) 03/2016 - 06/2006
3	Ischemia 02/2016 - 08/2006
3	Hereditary Angioedemas 12/2014 - 01/2004

Drug/Important Bio-Agent (IBA)

45	AnticoagulantsIBA 05/2024 - 06/2006
34	Hemostatics (Antihemorrhagics)IBA 02/2024 - 09/2005
32	Heparin (Liquaemin)FDA LinkGeneric 05/2024 - 07/2005
28	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 10/2018
19	AntithrombinsIBA 03/2024 - 01/2006
18	Fibrinogen (Factor I)FDA Link 02/2023 - 01/2004
12	Thrombin FDA Link 08/2023 - 02/2003
12	prothrombin complex concentrates (PPSB)IBA 02/2020 - 11/2008
11	Dabigatran FDA Link 08/2023 - 06/2013
11	recombinant FVIIa (rFVIIa)FDA Link 03/2016 - 06/2003
8	CytokinesIBA 05/2024 - 02/2003
8	ThrombomodulinIBA 12/2023 - 09/2017
8	fibrin fragment D (D-dimer)IBA 02/2023 - 09/2014
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 09/2004
7	Blood Coagulation Factors (Coagulation Factor)IBA 05/2024 - 03/2008
7	Tranexamic Acid (AMCA)FDA Link 12/2023 - 09/2014
7	Factor VIIa (Activated Factor VII)IBA 03/2016 - 01/2006
7	Aprotinin (Trasylol)FDA Link 02/2008 - 01/2004
6	VaccinesIBA 03/2024 - 07/2021
6	Oxygen (Dioxygen)IBA 02/2024 - 06/2003
6	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2019
6	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 02/2006
6	idarucizumabIBA 05/2017 - 07/2015
5	Thromboplastin (Tissue Factor)IBA 02/2023 - 02/2003
5	AntibodiesIBA 01/2023 - 02/2007
5	Vitamin K FDA Link 05/2020 - 05/2016
4	ChemokinesIBA 05/2024 - 11/2022
4	EnzymesIBA 03/2024 - 10/2009
4	Platelet Factor 4IBA 02/2023 - 02/2007
4	FibrinIBA 12/2021 - 01/2020
4	Hemoglobins (Hemoglobin)IBA 03/2019 - 05/2011
4	Warfarin (Coumadin)FDA LinkGeneric 05/2016 - 06/2013
4	clevidipine FDA Link 08/2014 - 05/2002
4	Complement C5 (Complement 5)IBA 07/2011 - 08/2006
4	pexelizumabIBA 07/2011 - 08/2006
3	Peptides (Polypeptides)IBA 05/2024 - 02/2008
3	Complement System Proteins (Complement)IBA 05/2024 - 02/2003
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2024 - 01/2020
3	argatroban (MPQA)FDA Link 02/2024 - 02/2007
3	Prothrombin (Factor II)IBA 08/2023 - 04/2014
3	von Willebrand FactorIBA 02/2023 - 12/2012
3	Protamines (Protamine Sulfate)FDA Link 01/2023 - 02/2008
3	EndotoxinsIBA 12/2020 - 02/2007
3	Simendan (Levosimendan)IBA 01/2020 - 12/2016
3	N(4)-oleylcytosine arabinosideIBA 01/2018 - 09/2014
3	Prasugrel Hydrochloride FDA Link 07/2013 - 07/2012
3	Clopidogrel (Plavix)FDA Link 07/2012 - 08/2004
3	HBOC 201 (Hemopure)IBA 06/2003 - 04/2002

Therapy/Procedure

51	Therapeutics 12/2023 - 02/2005
23	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2024 - 05/2004
13	Critical Care (Surgical Intensive Care) 02/2024 - 02/2010
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020 - 05/2004
7	Extracorporeal Membrane Oxygenation 03/2024 - 05/2013
6	Length of Stay 10/2023 - 08/2004
5	Resuscitation 04/2024 - 04/2015
5	Off-Label Use 08/2023 - 01/2006
4	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2024 - 12/2016
4	Hemodilution 11/2022 - 05/2009
4	Platelet Transfusion (Blood Platelet Transfusions) 12/2020 - 07/2012
4	Anticoagulation Reversal 05/2017 - 11/2008
3	Artificial Respiration (Mechanical Ventilation) 10/2023 - 01/2022
3	Blood Transfusion (Blood Transfusions) 10/2017 - 10/2007